Routine use of external cephalic version in three hospitals.
BACKGROUND
External cephalic version has been advocated as a safe alternative to vaginal breech delivery or cesarean birth. The purpose of this study was to determine the efficacy of routine use of external cephalic version at 36 weeks or more of gestation in three different levels of hospitals.


METHODS
External cephalic version was performed on 923 women with a single breech fetus at three hospitals in Italy. The procedure was attempted with a tocolytic agent for uterine relaxation and with no maternal analgesia. The version technique adopted was the "forward roll."


RESULTS
Version was successfully performed on 579 fetuses (62.7%); each hospital had a similar success rate, and 56.9 percent of the women delivered vaginally. The procedure was more successful in multiparas and in women with an incomplete type of breech, polyhydramnios, and posterior localization of the placenta. Vaginal bleeding was experienced by 14 women; eight cesarean sections were performed for suspected abruptio placentae, confirmed in four cases. Two cephalic-turned fetuses experienced an episode of persistent bradycardia and were turned again to breech; in five cases a nonstress test recorded after the version showed repeated variable decelerations and in one case a cesarean section was performed. Neonatal outcomes were good in 922 infants. A fracture of the femur attributable to the version was observed in one newborn.


CONCLUSIONS
External cephalic version is effective in reducing the number of cesarean deliveries in term breech infants in different obstetric settings, with no major neonatal adverse outcomes.
Regalia
A L
AL
Department of Obstetrics and Gynecology, S. Gerardo Hospital, Monza, Italy.
Curiel
P
P
Natale
N
N
Galluzzi
A
A
Spinelli
G
G
Ghezzi
G V
GV
Tampieri
A
A
Terzian
E
E
D000328:Adult; D001946:Breech Presentation; D005260:Female; D005323:Fetal Monitoring; D005865:Gestational Age; D006801:Humans; D007558:Italy; D015999:Multivariate Analysis; D010298:Parity; D011247:Pregnancy; D011256:Pregnancy Outcome; D015149:Tocolytic Agents / Q000627:therapeutic use; D014710:Version, Fetal / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data*
D015149:Tocolytic Agents